Plerixafor improves the mobilization of bone-marrow stem cells in healthy volunteers and substantially shortens the collection process. Medscape Medical News
Compared with arzoxifene, tamoxifen provides longer progression-free survival and time to treatment failure in women with locally advanced and metastatic breast cancer, according to a report in the November 1st Journal of Clinical Oncology. Reuters Health Information
Uninsured patients and those covered by Medicaid are far more likely to present with advanced-stage cancer at diagnosis than those with private coverage. Medscape Medical News
Trastuzumab may significantly improve survival among women with advanced breast cancer, but there are concerns about cardiotoxicity associated with this targeted therapy. The current analysis examines this issue and means to prevent cardiac events among women receiving trastuzumab. Nature Clinical Practice Oncology
In men with locally advanced prostate cancer, adding radiation to androgen deprivation therapy cuts in half the risk of dying from the disease. Medscape Medical News
